Address: Wai Chai District, Hong Kong Island

Products

Products > Peptides
GLP-1,  5mg/vial

GLP-1, 5mg/vial

Basic Info. GLP-1 agonists are a class of drugs primarily used for managing type 2 diabetes that have also proven to be helpful for supporting weight loss. These medications work by mimicking the actions of the  glucagon-like peptide-1 hormone, aiding in blood sugar regulation and promoting a feeling of fullness. ...

Read Details
Glutathione

Glutathione

Basic Info. Glutathione is a substance made from the amino acids glycine, cysteine, and glutamic acid. It is produced by the liver and involved in many body processes. Glutathione is involved in tissue building and repair, making chemicals and proteins needed in the body, and in immune system function. ...

Read Details
Insulin

Insulin

Basic Info. Insulin is a peptide hormone secreted by the pancreas that promotes the absorption and utilization of glucose in the liver and muscle tissue, thereby reducing blood sugar levels.  The main function of insulin is to help the body convert glucose in food into energy and store it in the liver and muscles ...

Read Details
ÎÞ¾úË®

ÎÞ¾úË®

Basic Info. Sterile water usually refers to water without bacteria obtained by treating water containing bacteria by physical methods, such as steam method, UHT heat method, ultraviolet sterilization, ozone method and physical filtration method, which kills microorganisms in water and filters it, and the inorganic salts in the water generally do not decrease. ...

Read Details
Botulinum toxin

Botulinum toxin

Basic Info. Botulinum toxin, or botulinum neurotoxin, is a highly potent neurotoxic protein produced by the bacterium Clostridium botulinum.  It's known for its ability to block nerve functions, leading to paralysis and is the cause of the disease botulism. Botulinum toxin is also used in small doses in medical and cosmetic applications, such as Botox injections for wrinkle reduction and other conditions.   ...

Read Details
5-amino-1MQ

5-amino-1MQ

Basic Info. 5-amino-1MQ is a small molecule drug that functions to block the activity of an enzyme called nicotinamide N-methyltransferase (NNMT). NNMT plays a significant role in metabolism and energy and is predominantly active in fat tissue.  By blocking NNMT, 5-amino-1MQ stimulates an increase in nicotinamide adenine dinucleotide (NAD+), a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1). SIRT1 is also known as ¡®the longevity gene¡¯ because of its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other forms of cardiovascular disease, kidney disease, liver disease,  neurodegeneration, and cancer. ...

Read Details
EPO

EPO

Basic Info. EPO injection (Erythropoietin Injection) is a medicine that helps your bone marrow to produce more red blood cells.It is used to treat a type of anemia caused by kidney disease.  It is also used to treat anemia caused by cancer chemotherapy and by taking medicines to treat HIV. ...

Read Details
Cerebrolysin

Cerebrolysin

Basic Info. Cerebrolysin, a neuropeptide preparation, has been extensively studied in rat models to evaluate its potential in treating neurological impairments. Research indicates that Cerebrolysin can significantly enhance cognitive functions and promote neuroprotection following brain injuries. It is rats subjected to mild traumatic brain injury (mTBI) were treated with Cerebrolysin. The results demonstrated notable improvements in long-term spatial learning and memory, as assessed by the Morris water maze test.  Additionally, treated rats exhibited reduced accumulation of amyloid precursor protein and decreased astrogliosis, suggesting neuroprotective effects. ...

Read Details
Ara-290

Ara-290

Basic Info. ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes. ARA 290  has been shown to be effective in the reduction of inflammation and activation of the healing process in a wide variety of preclinical models as well as in patients.  With respect to diabetes, substantial recent work has shown that rhEPO can improve the diabetic state in animal models . However, in addition to interacting with the innate repair receptor in a paracrine/autocrine manner, EPO also functions as a circulating hormone via its interaction with the EPO receptor homodimer that mediates hematopoiesis. ...

Read Details
Cagrilintide

Cagrilintide

Basic Info. Cagrilintide, a long-acting analogue of the hormone amylin, presents a promising new approach to tackling obesity.  Unlike many weight-loss drugs that only target one mechanism, cagrilintide works on multiple fronts. It suppresses appetite by promoting feelings of fullness (satiety) and slows down gastric emptying, making people feel full for longer periods of time.  Early trials of cagrilintide have shown that it leads to significant weight loss compared to placebo and even other peptides like liraglutide, which is currently used for obesity treatment. In one study, participants taking cagrilintide lost up to 10.8% of their body weight over 26 weeks, outperforming those on liraglutide. Sustained weight loss like this can help break the cycle of yo-yo dieting. ...

Read Details
snap-8

snap-8

Basic Info. SNAP-8 is an octapeptide widely used in skin care products. It can effectively reduce facial wrinkles, especially on the forehead and around the eyes. It is considered a natural alternative to Botox, which reduces wrinkles by reducing the contraction of facial muscles. It can also bind to neurotransmitter receptors on nerve cells, blocking the transmission of nerve signals, thereby reducing muscle contraction and wrinkle formation. It can also help improve the skin's barrier function, enhance the skin's resistance, prevent skin moisture loss, and maintain skin elasticity. ...

Read Details
Mazdutide

Mazdutide

Basic Info. Mazdutide is a dual  agonist  of the GLP-1 receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM).  The drug is developed by Eli Lilly and is currently in multiple Phase III studies.  In May 2025, a result of Phase III study has shown that once-weekly mazdutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity. ...

Read Details
Total:10 page, with 112 products